Your browser doesn't support javascript.
Durability of Immunity Is Low Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1, BA.2, and BA.3 Variants After Second and Third Vaccinations in Children and Young Adults With Inflammatory Bowel Disease Receiving Biologics.
Bellusci, Lorenza; Zahra, Fatema Tuz; Hopkins, Dena E; Salazar, Juan C; Hyams, Jeffrey S; Khurana, Surender.
  • Bellusci L; Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
  • Zahra FT; Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
  • Hopkins DE; Department of Pediatrics, Connecticut Children's Medical Center, Hartford, Connecticut; School of Medicine, University of Connecticut, Farmington, Connecticut.
  • Salazar JC; Department of Pediatrics, Connecticut Children's Medical Center, Hartford, Connecticut; School of Medicine, University of Connecticut, Farmington, Connecticut.
  • Hyams JS; Department of Pediatrics, Connecticut Children's Medical Center, Hartford, Connecticut; School of Medicine, University of Connecticut, Farmington, Connecticut.
  • Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland. Electronic address: Surender.Khurana@fda.hhs.gov.
Gastroenterology ; 163(6): 1672-1675, 2022 12.
Article in English | MEDLINE | ID: covidwho-2036950
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biological Products / Inflammatory Bowel Diseases / COVID-19 Topics: Vaccines / Variants Limits: Adult / Child / Humans / Young adult Language: English Journal: Gastroenterology Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biological Products / Inflammatory Bowel Diseases / COVID-19 Topics: Vaccines / Variants Limits: Adult / Child / Humans / Young adult Language: English Journal: Gastroenterology Year: 2022 Document Type: Article